Navigation Links
Privately owned genetic databases may hinder diagnosis and bar the way to the arrival of personalized medicine
Date:10/31/2012

In response to the on-line publication by the European Journal of Human Genetics today (Wednesday) of an article by US researchers led by Dr. Robert Cook-Degan, a former member of the US Office of Technology Assessment, showing that Myriad Genetics, providers of the BRCA1/2 genetic test in the US, has amassed vast quantities of clinical data without sharing it, Professor Martina Cornel, chair of the European Society of Human Genetics' Professional and Public Policy committee, said:

"We are very concerned that such important data is being withheld from those who most need it. Interpreting the variants of unknown significance (VUS) that may be found on analysing the patient's genome plays an essential part in being able to provide proper counselling and if necessary, preventive or therapeutic guidance. By not sharing their data on the VUS obtained from individuals undergoing BRCA1/2 testing, where Myriad is the sole commercial provider of a test in the US, geneticists have been unable to develop the up-to-date algorithms that are necessary to best interpret the effects of genetic variants. While Myriad has access to public databases in order to help interpret their VUS results, this is currently not reciprocal.

"We know that, regrettably, medical geographic inequities are common, but what is particularly worrying about this situation is that it is the first time that such inequities have been based on a lack of access to clinical information, rather than lack of a product. Myriad's stated aim to enter the European market more vigorously may lead to unfair competition with academic institutions for predictive precision. It is vital that progress towards personalised medicine, which holds out so much promise, is not hindered by companies maintaining private genomic databases. Policymakers should take an urgent look at the regulatory and reimbursement issues involved in genomic testing in order for all the data that is essential to understanding the clinical significance of VUS to be made public, to the benefit of patients and healthcare providers alike."


'/>"/>

Contact: Mary Rice
mary.rice@riceconseil.eu
European Society of Human Genetics
Source:Eurekalert

Related biology news :

1. Renowned geneticist R. Rodney Howell receives ACMG Foundation Lifetime Achievement Award
2. FirstMark Welcomes Renowned Cardiologist and Researcher Dr. Prediman K. Shah to Scientific Advisor Board
3. FirstMark Welcomes Renowned Cardiologist and Researcher Dr. Prediman K. Shah to Scientific Advisory Board
4. Nearby chimpanzee populations show much greater genetic diversity than distant human populations
5. Will a genetic mutation cause trouble? Ask Spliceman
6. UC Santa Barbara researchers discover genetic link between visual pathways of hydras and humans
7. Perception and preference may have genetic link to obesity
8. A foot in the door to genetic information
9. Genetic survey of endangered Antarctic blue whales shows surprising diversity
10. Epigenetic signatures direct the repair potential of reprogrammed cells
11. Epigenetics and epidemiology -- hip, hype and science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/2/2018)... , ... August 02, 2018 , ... ... solutions to pharmaceutical and biotech companies, today announced that Mark Jara, principal of ... inspiring people in the life sciences industry. Individuals named to PharmaVOICE 100 are ...
(Date:8/1/2018)... TUCSON, Ariz. & GILBERT, Ariz. (PRWEB) , ... ... ... Ever James A. May Father of Stevia Awards at Global Conference , Awards ... Michael P. May, Ph.D., president of Wisdom National Brands, presented prestigious stevia awards ...
(Date:7/31/2018)... ... 2018 , ... ACEA Biosciences, is a privately owned biotechnology company which develops ... xCELLigence RTCA S16, which the ideal entry level model for exploratory studies in cell ... placed in any standard CO2 tissue culture incubator. The user friendly RTCA software ...
Breaking Biology News(10 mins):
(Date:8/17/2018)... , ... August 16, 2018 , ... ... (CRO) is pleased to announce the expansion of their team. Dr. Dawn Dufield, ... to launch an innovative large molecule LC-MS/MS group that will specialize in developing ...
(Date:8/14/2018)... ... August 14, 2018 , ... Buprenorphine (BUP) is a ... is often prescribed as a sublingual co-formulation with the opioid antagonist naloxone (NXO) ... will learn from a review of the pharmacokinetics of BUP, NBP, and NXO ...
(Date:8/9/2018)... ... August 08, 2018 , ... ActX ... and is continually updated by a talented scientific team that includes geneticists, PharmD’s, ... , 1. Information on the medical impact of a patient’s genetic variants ...
(Date:8/9/2018)... ... August 09, 2018 , ... Rockland Immunochemicals, ... Dr. Birte Aggeler, Director of Antibody Development at Bio-Techne, composed a peer-reviewed article ... published online on August 9, 2018 and will be printed in the September ...
Breaking Biology Technology: